SOGUG-Vexillum: Phase II non-randomized clinical trial of nivolumab/ipilimumab maintenance following first-line chemotherapy in unresectable locally advanced or metastatic urothelial cancer. FGFR3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results